Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes

AIM: This retrospective cohort study evaluated whether metformin use in patients with type 2 diabetes mellitus might reduce the risk of biliary tract cancer (BTC); and explored whether metformin use might affect the overall survival in patients who developed BTC. METHODS: New-onset type 2 diabetes p...

Descripción completa

Detalles Bibliográficos
Autor principal: Tseng, Chin-Hsiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653020/
https://www.ncbi.nlm.nih.gov/pubmed/33194743
http://dx.doi.org/10.3389/fonc.2020.587666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653020/
https://www.ncbi.nlm.nih.gov/pubmed/33194743
http://dx.doi.org/10.3389/fonc.2020.587666

Ejemplares similares